FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126539610> ?p ?o ?g. }

• W3126539610 endingPage "166" @default.
• W3126539610 startingPage "165" @default.
• W3126539610 abstract "As the world continues to respond to the COVID-19 pandemic, robust evidence in specific populations is critical to guide clinical care and public health policy. The maternal-newborn population requires unique consideration owing to its increased vulnerability to respiratory infections and to medical interventions used to treat infection, as well as unique infection prevention and control needs during labour, delivery, and the postpartum period. In response to the need for quality evidence to support optimal clinical care of pregnant women and their infants, a large collaboration of researchers and clinicians across Canada rapidly initiated Canadian Surveillance of COVID-19 in Pregnancy (CANCOVID-Preg) to collect comprehensive information on outcomes for infected pregnant individuals and their newborns (https://ridprogram.med.ubc.ca/cancovid-preg/). When COVID-19 was declared a pandemic, reproductive infectious disease specialists across Canada began to conceptualize a national surveillance program through an existing network. Within 2 weeks of the pandemic being declared, national meetings and protocol development were initiated. The first all-member meeting occurred at 7 weeks, when organizational structures had been launched in all regions. This was accomplished before any funding was received, due to exemplary individual commitment in each region of the country. Calls for COVID-19–specific funding allowed for dedicated funding to be secured within 3 months. This pan-Canadian team, with representation from every province and territory, is a remarkable example of national collaboration. Our overall aim is to generate Canadian-specific clinical and epidemiological data on the impact of SARS-CoV-2 infection during pregnancy on maternal, fetal, and neonatal health. Functioning as an observational surveillance program, cases in each province/territory are identified through public health reporting or clinical case identification, with regionally adapted data collection according to a common standardized protocol. Ontario is leveraging the existing infrastructure of the Better Outcomes Registry & Network to collect parallel data for inclusion. Case ascertainment extends back to March 1, 2020, and will continue through the duration of the pandemic. The surveillance-based approach allows for a far reach into rural and remote communities. Not only will this project provide timely data to inform public health, it also will function as a platform for additional research by allowing researchers to obtain patient consent and collect biospecimens from a subset of affected pregnancies. As of September 25, 2020, more than 860 COVID-19–affected pregnancies have been identified across Canada. To facilitate use of data, a steering committee was established with operating principles of transparency, equitable data access, and international data sharing. This project is endorsed by the Public Health Agency of Canada, the Canadian Paediatric Society, and the Society of Obstetricians and Gynaecologists of Canada. Data collection has been harmonized with a number of other international registries for COVID-19 in pregnancy, including COVI-Preg,1Panchaud A Favre G Pomar L et al.An international registry for emergent pathogens and pregnancy..Lancet. 2020; 395: 1483-1484Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar the U.K. COVID in pregnancy registry, and the Global Research in Pregnancy and the Newborn Collaboration: COVID-19, led by a U.S.-based group and linked to the World Health Organization. Our neonatal data collection has been harmonized with iNeo, which is collecting data internationally on infants born to women with COVID-19 (http://www.ineonetwork.org/). There will be other opportunities for data sharing and collaboration with different international consortia, including those assessing the impact of COVID-19 on coagulopathy and thrombosis, with which we have harmonized data (ISTH COV-PREG-Coag Registry2Pregnancy and COVID-19 associated coagulopathy registry (COV-PREG-COAG). Available at: https://redcap.isth.org/surveys/?s=4JPX9W98RH. Accessed on November 8, 2020.Google Scholar). Given that many adverse outcomes in pregnancy may be low in frequency, international collaboration is critical to achieve numbers adequate to detect elevated risk and result in an improved global understanding of COVID-19 in pregnancy. CANCOVID-Preg is an example of a swift national response to an emerging pathogen that could be mobilized in future epidemics to provide rapid, high-quality data to support the public health response and clinical care of pregnant women and their families." @default.
• W3126539610 created "2021-02-15" @default.
• W3126539610 creator A5000723105 @default.
• W3126539610 creator A5002351734 @default.
• W3126539610 creator A5002946721 @default.
• W3126539610 creator A5003075860 @default.
• W3126539610 creator A5004187927 @default.
• W3126539610 creator A5009426298 @default.
• W3126539610 creator A5010815891 @default.
• W3126539610 creator A5016591054 @default.
• W3126539610 creator A5019517321 @default.
• W3126539610 creator A5026644112 @default.
• W3126539610 creator A5037832437 @default.
• W3126539610 creator A5039281133 @default.
• W3126539610 creator A5042594044 @default.
• W3126539610 creator A5045950999 @default.
• W3126539610 creator A5049163660 @default.
• W3126539610 creator A5059277164 @default.
• W3126539610 creator A5063830426 @default.
• W3126539610 creator A5068163031 @default.
• W3126539610 creator A5071379245 @default.
• W3126539610 creator A5081040274 @default.
• W3126539610 creator A5089011345 @default.
• W3126539610 creator A5091621411 @default.
• W3126539610 date "2021-02-01" @default.
• W3126539610 modified "2023-10-11" @default.
• W3126539610 title "Canadian Surveillance of COVID-19 in Pregnancy (CANCOVID-Preg): A Rapidly Coordinated National Response Using Established Regional Infrastructures" @default.
• W3126539610 cites W3017782803 @default.
• W3126539610 doi "https://doi.org/10.1016/j.jogc.2020.10.005" @default.
• W3126539610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8110247" @default.
• W3126539610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33546778" @default.
• W3126539610 hasPublicationYear "2021" @default.
• W3126539610 type Work @default.
• W3126539610 sameAs 3126539610 @default.
• W3126539610 citedByCount "5" @default.
• W3126539610 countsByYear W31265396102021 @default.
• W3126539610 countsByYear W31265396102022 @default.
• W3126539610 countsByYear W31265396102023 @default.
• W3126539610 crossrefType "journal-article" @default.
• W3126539610 hasAuthorship W3126539610A5000723105 @default.
• W3126539610 hasAuthorship W3126539610A5002351734 @default.
• W3126539610 hasAuthorship W3126539610A5002946721 @default.
• W3126539610 hasAuthorship W3126539610A5003075860 @default.
• W3126539610 hasAuthorship W3126539610A5004187927 @default.
• W3126539610 hasAuthorship W3126539610A5009426298 @default.
• W3126539610 hasAuthorship W3126539610A5010815891 @default.
• W3126539610 hasAuthorship W3126539610A5016591054 @default.
• W3126539610 hasAuthorship W3126539610A5019517321 @default.
• W3126539610 hasAuthorship W3126539610A5026644112 @default.
• W3126539610 hasAuthorship W3126539610A5037832437 @default.
• W3126539610 hasAuthorship W3126539610A5039281133 @default.
• W3126539610 hasAuthorship W3126539610A5042594044 @default.
• W3126539610 hasAuthorship W3126539610A5045950999 @default.
• W3126539610 hasAuthorship W3126539610A5049163660 @default.
• W3126539610 hasAuthorship W3126539610A5059277164 @default.
• W3126539610 hasAuthorship W3126539610A5063830426 @default.
• W3126539610 hasAuthorship W3126539610A5068163031 @default.
• W3126539610 hasAuthorship W3126539610A5071379245 @default.
• W3126539610 hasAuthorship W3126539610A5081040274 @default.
• W3126539610 hasAuthorship W3126539610A5089011345 @default.
• W3126539610 hasAuthorship W3126539610A5091621411 @default.
• W3126539610 hasBestOaLocation W31265396101 @default.
• W3126539610 hasConcept C116675565 @default.
• W3126539610 hasConcept C126322002 @default.
• W3126539610 hasConcept C159047783 @default.
• W3126539610 hasConcept C17744445 @default.
• W3126539610 hasConcept C199539241 @default.
• W3126539610 hasConcept C2778137277 @default.
• W3126539610 hasConcept C2779134260 @default.
• W3126539610 hasConcept C2779234561 @default.
• W3126539610 hasConcept C2779473830 @default.
• W3126539610 hasConcept C2909376813 @default.
• W3126539610 hasConcept C3006700255 @default.
• W3126539610 hasConcept C3007834351 @default.
• W3126539610 hasConcept C3008058167 @default.
• W3126539610 hasConcept C524204448 @default.
• W3126539610 hasConcept C54355233 @default.
• W3126539610 hasConcept C545542383 @default.
• W3126539610 hasConcept C71924100 @default.
• W3126539610 hasConcept C86803240 @default.
• W3126539610 hasConcept C89623803 @default.
• W3126539610 hasConceptScore W3126539610C116675565 @default.
• W3126539610 hasConceptScore W3126539610C126322002 @default.
• W3126539610 hasConceptScore W3126539610C159047783 @default.
• W3126539610 hasConceptScore W3126539610C17744445 @default.
• W3126539610 hasConceptScore W3126539610C199539241 @default.
• W3126539610 hasConceptScore W3126539610C2778137277 @default.
• W3126539610 hasConceptScore W3126539610C2779134260 @default.
• W3126539610 hasConceptScore W3126539610C2779234561 @default.
• W3126539610 hasConceptScore W3126539610C2779473830 @default.
• W3126539610 hasConceptScore W3126539610C2909376813 @default.
• W3126539610 hasConceptScore W3126539610C3006700255 @default.
• W3126539610 hasConceptScore W3126539610C3007834351 @default.
• W3126539610 hasConceptScore W3126539610C3008058167 @default.
• W3126539610 hasConceptScore W3126539610C524204448 @default.
• W3126539610 hasConceptScore W3126539610C54355233 @default.
• W3126539610 hasConceptScore W3126539610C545542383 @default.
• W3126539610 hasConceptScore W3126539610C71924100 @default.

• next